A national innovation system for pharma

Part one of this article (Business Standard, May 18, 2023) argued that in building an effective national innovation system, we should learn from the most successful economic development stories of the last 70 years: In Japan, South Korea, Taiwan, Singapore and China. “Each followed a sequence in building innovation capacity…. of a competitive industry followed by deepening technical sophistication followed by in-house R&D followed by public research…” Our best bet for a world-beating industry built on innovation is in pharmaceuticals, the one industry where we come close to world levels of investment in R&D. What does it take to get there?  We draw (anonymously, as we were operating under Chatham House rules) on the comments made in a recent closed-door roundtable on innovation in the pharmaceutical industry, attended by some of our most insightful leaders from industry, academia and government, jointly hosted by the Centre for Technology

Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www.business-standard.com or the Business Standard newspaper

First Published: Jun 20 2023 | 4:53 PM IST

No Byline Policy

Editorial Guidelines

Corrections Policy

Source